Fidson Healthcare Plc delivered a significantly stronger financial performance for the year ended December 31, 2025, which was a record-breaking year for the national drug maker.
Revenue growth has accelerated over the past few years, from N53.1 billion in 2023 to N84.2 billion in 2024, before su
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
